ArticlePloS one2019

Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification.

Haim Matzkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.